Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenhui Lou

Showing results (41-50 of 165) with videos related to

Pageof 17
Sort By:
Journal of Zhejiang University. Science. B|December 14, 2021
Basophils as a potential therapeutic target in cancerJicheng Zhang, Hanlin Yin, Qiangda Chen, et al.
Journal of Cellular and Molecular Medicine|July 10, 2020
CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancerQiangda Chen, Ning Pu, Hanlin Yin, et al.
Journal of Fish Biology|May 5, 2026
Characterization of the corticotropin-releasing hormone family in largemouth bass and their expression profiles in response to feeding and acute and chronic heat stressJinxing Du, Wenhui Lou, Tao Zhu, et al.
BMC Gastroenterology|July 1, 2010
Proteomics analysis of serum protein profiling in pancreatic cancer patients by DIGE: up-regulation of mannose-binding lectin 2 and myosin light chain kinase 2Yefei Rong, Dayong Jin, Chenrui Hou, et al.
Oncotarget|February 1, 2018
The value of systemic inflammatory markers in identifying malignancy in mucinous pancreatic cystic neoplasmsWentao Zhou, Yefei Rong, Tiantao Kuang, et al.
British Journal of Cancer|February 14, 2018
A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipelineXiaohui Liu, Weimin Zheng, Wansheng Wang, et al.
British Journal of Cancer|November 11, 2017
A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipelineXiaohui Liu, Weimin Zheng, Wansheng Wang, et al.
BMC Cancer|June 19, 2009
Induction of protective and therapeutic anti-pancreatic cancer immunity using a reconstructed MUC1 DNA vaccineYefei Rong, Dayong Jin, Wenchuan Wu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 29, 2011
IRF-2 is over-expressed in pancreatic cancer and promotes the growth of pancreatic cancer cellsLei Cui, Yuezhen Deng, Yefei Rong, et al.
The Journal of Pathology|November 7, 2020
Basal microvilli define the metabolic capacity and lethal phenotype of pancreatic cancerXu Han, Lixiang Ma, Jichun Gu, et al.
Pageof 17

Showing results (41-50 of 165) with videos related to

Sort By:
Pageof 17
Journal of Zhejiang University. Science. B|December 14, 2021
Basophils as a potential therapeutic target in cancerJicheng Zhang, Hanlin Yin, Qiangda Chen, et al.
Journal of Cellular and Molecular Medicine|July 10, 2020
CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancerQiangda Chen, Ning Pu, Hanlin Yin, et al.
Journal of Fish Biology|May 5, 2026
Characterization of the corticotropin-releasing hormone family in largemouth bass and their expression profiles in response to feeding and acute and chronic heat stressJinxing Du, Wenhui Lou, Tao Zhu, et al.
BMC Gastroenterology|July 1, 2010
Proteomics analysis of serum protein profiling in pancreatic cancer patients by DIGE: up-regulation of mannose-binding lectin 2 and myosin light chain kinase 2Yefei Rong, Dayong Jin, Chenrui Hou, et al.
Oncotarget|February 1, 2018
The value of systemic inflammatory markers in identifying malignancy in mucinous pancreatic cystic neoplasmsWentao Zhou, Yefei Rong, Tiantao Kuang, et al.
British Journal of Cancer|February 14, 2018
A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipelineXiaohui Liu, Weimin Zheng, Wansheng Wang, et al.
British Journal of Cancer|November 11, 2017
A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipelineXiaohui Liu, Weimin Zheng, Wansheng Wang, et al.
BMC Cancer|June 19, 2009
Induction of protective and therapeutic anti-pancreatic cancer immunity using a reconstructed MUC1 DNA vaccineYefei Rong, Dayong Jin, Wenchuan Wu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 29, 2011
IRF-2 is over-expressed in pancreatic cancer and promotes the growth of pancreatic cancer cellsLei Cui, Yuezhen Deng, Yefei Rong, et al.
The Journal of Pathology|November 7, 2020
Basal microvilli define the metabolic capacity and lethal phenotype of pancreatic cancerXu Han, Lixiang Ma, Jichun Gu, et al.
Pageof 17